LAUREN HAMANN: Open Payments
NPI 1447994207 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 24 payments from 7 companies in 2025. Trend: 2023 $377 · 2024 $469 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 12 | $262 |
| Insulet Corporation | 3 | $185 |
| Novo Nordisk Inc | 2 | $60 |
| Tandem Diabetes Care, Inc. | 3 | $47 |
| BETA BIONICS, INC. | 2 | $25 |
| Medtronic, Inc. | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $19 |
Products named: Omnipod, DEXCOM G7 GSS (161), Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, Wegovy, Ozempic, iLet Bionic Pancreas, MINIMED 780G.
Industry payments across CT — which companies pay providers there.
